Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Califf Supports Combo Products Pathway At Confirmation Hearing

This article was originally published in The Gray Sheet

Executive Summary

FDA's concepts for a new pathway could be ready for congressional scrutiny within a year, Deputy Commission Robert Califf said during his confirmation hearing before the Senate HELP Committee. Most committee members expressed support for Califf's nomination to lead FDA, although he fielded some questions on his ties to industry.

Advertisement

Related Content

Combo Products Won't Get Special Review Pathway At US FDA Anytime Soon
Postmarket Device Surveillance Reforms Raised At Califf Confirmation Hearing
On Eve Of House Hearing, FDA Makes Its Case For LDT Framework
Consumer Groups Oppose Califf To Head FDA, Citing Industry Ties
Senate Bill Aimed At Streamlining Combo Product Regulation
Combo Product Reforms Are A Priority For Next User Fee Round, FDA Officials Say
Podcast: FDA's Califf Talks About Combo Product Reform, Commish Prospects
Human Factors Questions Drive Rise In FDA Inter-Center Consults
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
Ball In Judge’s Court In Combination Product Classification Suit

Topics

Advertisement
UsernamePublicRestriction

Register

MT034393

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel